Profund Advisors LLC Ligand Pharmaceuticals Inc Transaction History

Profund Advisors LLC

$2.59 Billion
Q3 2024

A detailed history of Profund Advisors LLC transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Profund Advisors LLC holds 2,917 shares of LGND stock, worth $325,420. This represents 0.01% of its overall portfolio holdings.

Number of Shares

2,917

Previous 3,155 7.54%

Holding current value

$325,420

Previous $265,000 10.19%

% of portfolio

0.01%

Previous 0.01%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$82.7 - $110.11 $19,682 - $26,206	-238 Reduced 7.54%	2,917 $292,000
Q2 2024 Aug 13, 2024	BUY	$68.53 - $87.91 $216,212 - $277,356	3,155 New	3,155 $265,000
Q1 2023 May 11, 2023	BUY	$65.67 - $77.08 $197,666 - $232,010	3,010 New	3,010 $221,000
Q1 2022 May 10, 2022	SELL	$94.99 - $151.56 $140,870 - $224,763	-1,483 Closed	0 $0
Q4 2021 Feb 08, 2022	SELL	$127.69 - $165.85 $21,324 - $27,696	-167 Reduced 10.12%	1,483 $229,000
Q3 2021 Nov 12, 2021	BUY	$102.33 - $144.73 $168,844 - $238,804	1,650 New	1,650 $230,000
Q2 2021 Aug 12, 2021	SELL	$113.03 - $155.64 $150,329 - $207,001	-1,330 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$99.52 - $215.83 $132,361 - $287,053	1,330 New	1,330 $203,000
Q3 2019 Nov 12, 2019	SELL	$86.25 - $120.16 $602,370 - $839,197	-6,984 Closed	0 $0
Q2 2019 Aug 13, 2019	SELL	$107.38 - $129.34 $67,649 - $81,484	-630 Reduced 8.27%	6,984 $797,000
Q1 2019 May 15, 2019	BUY	$105.93 - $142.47 $66,100 - $88,901	624 Added 8.93%	7,614 $957,000
Q4 2018 Feb 14, 2019	SELL	$128.36 - $272.13 $491,747 - $1.04 Million	-3,831 Reduced 35.4%	6,990 $949,000
Q3 2018 Nov 13, 2018	SELL	$211.18 - $274.49 $6,546 - $8,509	-31 Reduced 0.29%	10,821 $2.97 Million
Q2 2018 Aug 13, 2018	BUY	$150.77 - $207.98 $25,178 - $34,732	167 Added 1.56%	10,852 $2.25 Million
Q1 2018 May 14, 2018	BUY	$138.63 - $182.62 $92,882 - $122,355	670 Added 6.69%	10,685 $1.77 Million
Q4 2017 Feb 14, 2018	SELL	$128.36 - $147.04 $122,070 - $139,835	-951 Reduced 8.67%	10,015 $1.37 Million
Q3 2017 Nov 13, 2017	BUY	$120.91 - $137.94 $81,856 - $93,385	677 Added 6.58%	10,966 $1.49 Million
Q2 2017 Aug 11, 2017	BUY	N/A	10,289	10,289 $1.25 Million

Others Institutions Holding LGND

# of Institutions

257

Shares Held

18.2M

Call Options Held

26.8K

Put Options Held

9.3K

View Full List

About LIGAND PHARMACEUTICALS INC

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.88B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

More about LGND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Profund Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Profund Advisors LLC with notifications on news.

Account

Profund Advisors LLC Ligand Pharmaceuticals Inc Transaction History